|
Targeted treatment Perjeta (pertuzumab) gets regulatory green light in UK for use in
Perjeta regimen nearly doubled number of women whose tumours are eradicated versus standard treatmentOver 1,800 women per year in the UK2 with an aggressive type of breast cancer could...
More... |
| All times are GMT -7. The time now is 07:26 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021